title: Lipodystrophy associated with nevirapine-containing antiretroviral therapies.
authors.forename: T
authors.initials: T
authors.lastname: Aldeen
authors.forename: C
authors.initials: C
authors.lastname: Wells
authors.forename: P
authors.initials: P
authors.lastname: Hay
authors.forename: F
authors.initials: F
authors.lastname: Davidson
authors.forename: R
authors.initials: R
authors.lastname: Lau
mesh_terms: D000328:Adult; D019380:Anti-HIV Agents / Q000009:adverse effects* / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D008060:Lipodystrophy / Q000139:chemically induced* / Q000150:complications; D008297:Male; D008875:Middle Aged; D019829:Nevirapine / Q000009:adverse effects* / Q000627:therapeutic use; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D019380:Anti-HIV Agents; D018894:Reverse Transcriptase Inhibitors; D019829:Nevirapine